KOOIJ LOUISE FREDERIKA (Chief Accounting Officer) sold 17.6% of their position (2.65K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $88.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006659
Officer· Chief Accounting Officer
Since Jan 2026
+62.85K
Net shares
Net buyer
$88.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
65.50K acquired · 2.65K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−2.65K
Price / share
$33.25
Trade value
$88.01K
% of position
17.6%
1/5/2026
15K→12.35K
Ordinary Shares
Direct
Shares
+12K
Price / share
—
Trade value
—
% of position
97.1%
1/7/2026
12.35K→24.35K
Total
Net shares
+9.35K
Net value
-$88.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/5/2026 | S · Sale | −2.65K | $33.25 | $88.01K | 17.6% | 15K | 12.35K |
| Ordinary Shares Direct | 1/7/2026 | A · Award | +12K | — | — | 97.1% | 12.35K | 24.35K |
| Total | +9.35K | -$88.01K | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
53.50K shares
Shares
+53.50K
Strike price
35.45
Held after
53.50K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares53.50K shares | 1/7/2026 | A · Award | +53.50K | 35.45 | — | 53.50K |